Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

AstraZeneca Pharma India Results Update

AstraZeneca Pharma India reported 30% growth in Q2 results, with three new regulatory approvals. It also announced MoUs with two state governments.

Source

BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

AstraZeneca Pharma India Ltd: key numbers

Share price
₹6,294.00
Market cap
₹15,735 Cr
Revenue (annual)
₹2,276 Cr
Net profit (annual)
₹187.5 Cr
P/E (TTM)
92.8×Sector 37.9×
Promoter holding
75.00%+0.00% QoQ
FII holding
2.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from AstraZeneca Pharma India Ltd

All →

Other results update announcements

All →